Using dermatoscopy to guide skin cancer surgery
Dermatoscopy Guided Resection Margins in Basal Cell Carcinoma and Cutaneos Squamous Cell Carcinoma
This study is testing if using a special skin imaging tool called dermatoscopy can help doctors remove all of the cancer during surgery for patients with certain types of skin cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Region Örebro County Academic / other |
| Locations | 1 site (Örebro) |
| Trial ID | NCT06342297 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of dermatoscopy in determining the surgical margins for patients with suspected or confirmed basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC). In a randomized controlled design, 400 patients will be divided into two groups: one group will have their surgical margins decided using dermatoscopy, while the control group will not utilize this technique. The primary outcome will be the rate of radical versus non-radical resections as indicated in pathology reports. The goal is to improve the proportion of tumors that are completely removed during the initial surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with primary suspected or verified basal cell carcinoma or cutaneous squamous cell carcinoma.
Not a fit: Patients with recurrent tumors or those who have previously undergone radiotherapy in the tumor area may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to higher rates of complete tumor removal, reducing the likelihood of recurrence and improving patient outcomes.
How similar studies have performed: While the use of dermatoscopy in surgical decision-making is established, this specific approach in a randomized controlled trial setting is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with primary suspected or verified basal cell carcinoma or cutaneous cell carcinoma Exclusion Criteria: * Recurrent tumours * Previous radiotherapy of the tumour area * If the patient cannot understand the study i nformation
Where this trial is running
Örebro
- Örebro University Hospital — Örebro, Sweden (Recruiting)
Study contacts
- Study coordinator: Fredrik Landström, MD, PhD
- Email: fredrik.landstrom@regionorebrolan.se
- Phone: 019 602 14 68
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.